Jan-Willem E. M. Sels
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jan-Willem E. M. Sels has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Bas C. T. van Bussel
Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands
5 shared publications - Iwan Cornelis Clemens van der Horst
Albert Schweitzer Hospital, Dordrecht, the Netherlands
4 shared publications - Frank van Rosmalen
Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands
3 shared publications - Rob Godefridus Hubertus Driessen
Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands
3 shared publications - Eline G. M. Cox
Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands
2 shared publications - Gerhardus Johannes Albert Josef Maria Kuiper
Department of Anesthesiology and Pain Treatment, Maastricht University Medical Center, Maastricht, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Springer Nature in Critical Care
A comprehensive PROBAST-based assessment of mortality prediction models in adult intensive care units; an updated scoping review
Background: Numerous mortality prediction models have been developed for general adult intensive care unit (ICU) populations, but concerns remain regarding their methodological quality, risk of bias, and validation. Previous reviews primarily identified available models and their predictors, without a comprehensive model-by-model risk-of-bias assessment. We therefore updated the existing evidence base and systematically assessed identified ICU mortality prediction models using the Prediction model Risk Of Bias ASsessment Tool (PROBAST), aiming to identify methodologically robust models warranting further validation. Methods and results: We built on a systematic scoping review and its first update covering studies published up to February 8, 2023, and updated the search in PubMed (MEDLINE), Embase (Ovid), Web of Science, and CENTRAL through May 11, 2026. Eligible studies developed mortality prediction models for general adult critically ill populations. Data extraction and PROBAST assessment were performed independently by reviewer pairs using a standardized CHARMS- and PROBAST-based form. In total, 56 studies describing 84 mortality prediction models were included. Overall, 82/84 (98%) models were judged at high risk of bias, predominantly because of shortcomings in the analysis domain. Internal validation was absent in 21/84 (25%) models, while only 2/84 (2%) underwent external validation in the original publication. Only one model, ICNARC II, was judged at overall low risk of bias, while PREDICT was judged at unclear risk of bias. A prospective citation search identified no external validation studies for either model. Conclusion: Nearly all identified ICU mortality prediction models were at high risk of bias, limiting confidence in their reported performance and practical implementation of their intended use. Rather than continuing to develop additional models, future research should prioritize rigorous external validation and, where necessary, updating of promising existing models while adhering to established methodological standards.
- 12 November 2026
- Published by Springer Nature in Critical Care
Open AccessA comprehensive PROBAST-based assessment of mortality prediction models in adult intensive care units; an updated scoping review
Background: Numerous mortality prediction models have been developed for general adult intensive care unit (ICU) populations, but concerns remain regarding their methodological quality, risk of bias, and validation. Previous reviews primarily identified available models and their predictors, without a comprehensive model-by-model risk-of-bias assessment. We therefore updated the existing evidence base and systematically assessed identified ICU mortality prediction models using the Prediction model Risk Of Bias ASsessment Tool (PROBAST), aiming to identify methodologically robust models warranting further validation. Methods and results: We built on a systematic scoping review and its first update covering studies published up to February 8, 2023, and updated the search in PubMed (MEDLINE), Embase (Ovid), Web of Science, and CENTRAL through May 11, 2026. Eligible studies developed mortality prediction models for general adult critically ill populations. Data extraction and PROBAST assessment were performed independently by reviewer pairs using a standardized CHARMS- and PROBAST-based form. In total, 56 studies describing 84 mortality prediction models were included. Overall, 82/84 (98%) models were judged at high risk of bias, predominantly because of shortcomings in the analysis domain. Internal validation was absent in 21/84 (25%) models, while only 2/84 (2%) underwent external validation in the original publication. Only one model, ICNARC II, was judged at overall low risk of bias, while PREDICT was judged at unclear risk of bias. A prospective citation search identified no external validation studies for either model. Conclusion: Nearly all identified ICU mortality prediction models were at high risk of bias, limiting confidence in their reported performance and practical implementation of their intended use. Rather than continuing to develop additional models, future research should prioritize rigorous external validation and, where necessary, updating of promising existing models while adhering to established methodological standards.
- Open Access
- 10 September 2026
- Published by Wiley in International Journal for Numerical Methods in Biomedical Engineering
- Vol. 42 (9) , e70209
A Real‐Time Digital Twin for Human Cardiovascular Applications
Digital twin (DT) technology is revolutionizing various industries and has immense potential in healthcare as well. A human DT is a virtual representation of an individual patient, capable of mimicking the current (patho)physiological state and predicting future states, making it ideal for supporting clinical decision‐making. A DT combines a mathematical model with real‐time data; however, its development remains challenging. It must estimate a unique parameter value whenever a measurement becomes available, enabling real‐time tracking of parameter change, while preserving model stability. The DT was designed based on a reduced‐order unscented Kalman filter (ROUKF), using a lumped‐parameter model of the systemic circulation, to estimate left ventricular contractility. This DT was evaluated using both synthetic and in vivo left ventricle pressure data, the latter collected by Johnson et al. Synthetic data were used for local sensitivity, identifiability, and stability analysis, as well as to evaluate the DTs performance. In vivo data were used to evaluate the DTs potential for future clinical application. The DT estimated the true parameter in real‐time, remained robust to measurement noise, and tracked parameter changes independent of initial conditions. The parameter estimate was identifiable despite measurement noise, and the mathematical model proved stable within a physiologically realistic range. Application to in vivo data demonstrated successful tracking of inotropic state changes, with the estimated parameter showing a strong correlation with the conventional contractility proxy () in multiple patients. Overall, the results demonstrated the DTs potential for real‐time monitoring and personalized medicine, though future work is needed.
- 10 September 2026
- Published by Wiley in International Journal for Numerical Methods in Biomedical Engineering
- Vol. 42 (9) , e70209
Open AccessA Real‐Time Digital Twin for Human Cardiovascular Applications
Digital twin (DT) technology is revolutionizing various industries and has immense potential in healthcare as well. A human DT is a virtual representation of an individual patient, capable of mimicking the current (patho)physiological state and predicting future states, making it ideal for supporting clinical decision‐making. A DT combines a mathematical model with real‐time data; however, its development remains challenging. It must estimate a unique parameter value whenever a measurement becomes available, enabling real‐time tracking of parameter change, while preserving model stability. The DT was designed based on a reduced‐order unscented Kalman filter (ROUKF), using a lumped‐parameter model of the systemic circulation, to estimate left ventricular contractility. This DT was evaluated using both synthetic and in vivo left ventricle pressure data, the latter collected by Johnson et al. Synthetic data were used for local sensitivity, identifiability, and stability analysis, as well as to evaluate the DTs performance. In vivo data were used to evaluate the DTs potential for future clinical application. The DT estimated the true parameter in real‐time, remained robust to measurement noise, and tracked parameter changes independent of initial conditions. The parameter estimate was identifiable despite measurement noise, and the mathematical model proved stable within a physiologically realistic range. Application to in vivo data demonstrated successful tracking of inotropic state changes, with the estimated parameter showing a strong correlation with the conventional contractility proxy () in multiple patients. Overall, the results demonstrated the DTs potential for real‐time monitoring and personalized medicine, though future work is needed.
- Open Access
- 5 August 2026
- Published by Elsevier in SSRN Electronic Journal
Rotational thromboelastometry diagnostics and treatments in 9353 critically ill surgical and non-surgical intensive care patients; a single centre cohort study
BackgroundRotational thromboelastometry (ROTEM) provides a dynamic assessment of hemostasis in critically ill patients. However, observational studies evaluating ROTEM-guided therapeutic interventions in intensive care units (ICUs) are scarce.ObjectivesTo evaluate the use of ROTEM as routine protocolized care versus indication-based testing and its association with therapeutic interventions in ICU patients.MethodsA single-centre retrospective observational cohort study was conducted at Maastricht University Medical Centre+ between 2013 and 2024. ICU patients who underwent at least one ROTEM measurement were included. ROTEM findings and clinical interventions were compared across four patient groups: elective and emergency cardiothoracic surgery (CTS; routine protocolized ROTEM) and general surgery and non-surgical patients (indication-based ROTEM).ResultsA total of 9141 ICU patients were included: 6739 elective CTS, 489 emergency CTS, 1142 non-surgical, and 771 general surgery patients. Abnormal ROTEM results were more frequent in indication-based groups (39.9-41.9%) compared to routine-based groups (16.3-27.8%; p<0.001). Drug-based interventions and transfusions were also more common in clinically indication-based groups. Actual clinical interventions mirrored this distribution. ConclusionsROTEM abnormalities and associated therapeutic interventions were more frequent when testing was performed based on clinical indication, as compared to routine protocolized care. These findings suggest routine protocolized ROTEM testing in CTS patients is less effective than a strategy based on clinical indication.
- 5 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRotational thromboelastometry diagnostics and treatments in 9353 critically ill surgical and non-surgical intensive care patients; a single centre cohort study
BackgroundRotational thromboelastometry (ROTEM) provides a dynamic assessment of hemostasis in critically ill patients. However, observational studies evaluating ROTEM-guided therapeutic interventions in intensive care units (ICUs) are scarce.ObjectivesTo evaluate the use of ROTEM as routine protocolized care versus indication-based testing and its association with therapeutic interventions in ICU patients.MethodsA single-centre retrospective observational cohort study was conducted at Maastricht University Medical Centre+ between 2013 and 2024. ICU patients who underwent at least one ROTEM measurement were included. ROTEM findings and clinical interventions were compared across four patient groups: elective and emergency cardiothoracic surgery (CTS; routine protocolized ROTEM) and general surgery and non-surgical patients (indication-based ROTEM).ResultsA total of 9141 ICU patients were included: 6739 elective CTS, 489 emergency CTS, 1142 non-surgical, and 771 general surgery patients. Abnormal ROTEM results were more frequent in indication-based groups (39.9-41.9%) compared to routine-based groups (16.3-27.8%; p<0.001). Drug-based interventions and transfusions were also more common in clinically indication-based groups. Actual clinical interventions mirrored this distribution. ConclusionsROTEM abnormalities and associated therapeutic interventions were more frequent when testing was performed based on clinical indication, as compared to routine protocolized care. These findings suggest routine protocolized ROTEM testing in CTS patients is less effective than a strategy based on clinical indication.
- Open Access
- 1 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Boosting the accuracy of existing models by updating and extending: using a multicenter COVID-19 ICU cohort as a proxy
Most published prediction models for Coronavirus Disease 2019 (COVID-19) were poorly reported, at high risk of bias, and heterogeneous in model performance. To tackle methodological challenges faced in previous prediction studies, we investigated whether model updating and extending improves mortality prediction, using the Intensive Care Unit (ICU) as a proxy. All COVID-19 patients admitted to seven ICUs in the Euregio-Meuse Rhine during the first pandemic wave were included. The 4C Mortality and SEIMC scores were selected as promising prognostic models from an external validation study. Five predictors could be estimated based on cohort size. TRIPOD guidelines were followed and logistic regression analyses with the linear predictor, APACHE II score, and country were performed. Bootstrapping with backward selection was applied to select variables for the final model. Additionally, shrinkage was performed. Model discrimination was displayed as optimism-corrected areas under the ROC curve and calibration by calibration slopes and plots. The mortality rate of the 551 included patients was 36%. Discrimination of the 4C Mortality and SEIMC scores increased from 0.70 to 0.74 and 0.70 to 0.73 and calibration plots improved compared to the original models after updating and extending. Mortality prediction can be improved after updating and extending of promising models.
- 1 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Open AccessBoosting the accuracy of existing models by updating and extending: using a multicenter COVID-19 ICU cohort as a proxy
Most published prediction models for Coronavirus Disease 2019 (COVID-19) were poorly reported, at high risk of bias, and heterogeneous in model performance. To tackle methodological challenges faced in previous prediction studies, we investigated whether model updating and extending improves mortality prediction, using the Intensive Care Unit (ICU) as a proxy. All COVID-19 patients admitted to seven ICUs in the Euregio-Meuse Rhine during the first pandemic wave were included. The 4C Mortality and SEIMC scores were selected as promising prognostic models from an external validation study. Five predictors could be estimated based on cohort size. TRIPOD guidelines were followed and logistic regression analyses with the linear predictor, APACHE II score, and country were performed. Bootstrapping with backward selection was applied to select variables for the final model. Additionally, shrinkage was performed. Model discrimination was displayed as optimism-corrected areas under the ROC curve and calibration by calibration slopes and plots. The mortality rate of the 551 included patients was 36%. Discrimination of the 4C Mortality and SEIMC scores increased from 0.70 to 0.74 and 0.70 to 0.73 and calibration plots improved compared to the original models after updating and extending. Mortality prediction can be improved after updating and extending of promising models.
- Open Access
- 1 January 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 163, 25-31
Meta-Analysis Evaluating High-Sensitivity Cardiac Troponin T Kinetics after Coronary Artery Bypass Grafting in Relation to the Current Definitions of Myocardial Infarction
- 1 January 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 163, 25-31
Open AccessMeta-Analysis Evaluating High-Sensitivity Cardiac Troponin T Kinetics after Coronary Artery Bypass Grafting in Relation to the Current Definitions of Myocardial Infarction
- Open Access
- 1 August 2021
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 5 (6) , e12579
Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge
- 1 August 2021
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 5 (6) , e12579
Open AccessHemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge